Why Audentes Therapeutics Stock Is Skyrocketing Today

Shares of Audentes Therapeutics (NASDAQ: BOLD) are skyrocketing today, up by 105% as of 2:47 p.m. EST, after the clinical-stage gene therapy specialist announced it has agreed to be acquired.

Astellas Pharma, a pharmaceutical company based in Japan, has agreed to purchase Audentes Therapeutics.

Here are the key terms of the deal:

Continue reading

Source Fool.com